CDKN2A and pulmonary fibrosis: In lung tissue from RIPF patients and a mouse model of pulmonary fibrosis treated with bleomycin, the content of p16INK4a increased with senescent cells, suggesting the correlation between p16INK4a levels and the severity of fibrosis (Liggett and Sidransky 1998; Carraro et al., 2020).